Clinical Trials Logo

Clinical Trial Summary

This trial is to show the diagnostic efficacy of Gadovist for contrast enhanced magnetic resonance angiography (CE-MRA) of the arteries.


Clinical Trial Description

This trial is to show the diagnostic efficacy of Gadovist for contrast enhanced Magnetic Resonance Angiography (CE-MRA) of arteries (specified vessel segments) by analyzing the rate of agreement, image quality, and diagnostic confidence between a CE-MRA based diagnosis and the diagnosis achieved from the comparator procedure IA DSA using Ultravist. ;


Study Design

Allocation: Non-Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


NCT number NCT00154648
Study type Interventional
Source National Taiwan University Hospital
Contact Hon-Man Liu, MD
Phone 23123456
Status Recruiting
Phase Phase 4
Start date June 2005

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03768999 - Comparison of Magnetic Resonance Coronary Angiography (MRCA) With Coronary Computed Tomography Angiography (CTA)
Completed NCT04189068 - Fatal Cerebral Infarction After Nasal Augmentation With Hyaluronic Acid
Completed NCT02155218 - Improving the Concentration of MR Contrast in the Arteries N/A
Completed NCT01095081 - GARDIAN, Gadovist in Routine Diagnostic Magnetic Resonance Imaging Administration in Non-selected Patients N/A
Completed NCT00652418 - Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Magnetic Resonance Angiography Phase 2
Recruiting NCT03117218 - Correlation Between Quantitative Analysis of Coronary MRA and FFR N/A
Completed NCT02997046 - Ferumoxytol Enhanced Magnetic Resonance Angiography in Chronic Kidney Disease
Completed NCT04312711 - 3D Time-of-Flight Magnetic Resonance Angiography in Hemodialysis Patients With Arteriovenous Fistula N/A